查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844170

按產品類型、應用、最終用戶、技術和患者類型分類的血液分離設備市場—2025-2032年全球預測

Apheresis Equipment Market by Product Type, Application, End User, Technology, Patient Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液分離設備市場將成長至 64.5 億美元，複合年成長率為 9.34%。

主要市場統計數據
基準年 2024 31.5億美元
預計年份：2025年 34.5億美元
預測年份：2032年 64.5億美元
複合年成長率 (%) 9.34%

為血液分離設備的發展奠定基礎：影響採購和臨床應用的臨床促進因素、技術選擇和營運現實

血液分離設備處於臨床照護、細胞治療創新和捐贈者管理的交匯點，影響血液成分和治療性細胞的採集、處理和輸送方式。系統自動化、耗材設計和病原體控制的最新進展拓展了設備的功能範圍，使CAR-T細胞療法和幹細胞療法的細胞採集流程更加精準，同時支持可擴展的血漿捐獻和治療性血液分離術。同時，應用場所的多樣化——從專科醫院和血液中心到研究機構和社區診所——推動了對更多樣化的設備外形和服務模式的需求，並日益重視易用性、安全性和與臨床實驗室的下游整合。

實際上，相關人員平衡資本投入與日常耗材需求，將技術選擇與臨床方案和病患類型結合，並維持關鍵套件和配件的供應鏈連續性。離心機和膜平台等技術選擇會影響自動化程度、處理量和臨床人員培訓，並持續影響工作流程設計。包括綜合醫院和專科醫院、血站以及學術和商業研究實驗室在內的最終用戶在選擇設備時，會優先考慮可靠性、供應商支援和臨床證據。同時，監管監測和捐贈者安全要求也會影響不同地區設備的接受度和臨床應用。這些因素共同作用，使得血液分離設備在技術上既複雜又具有重要的戰略意義，對醫療機構、製造商和研究機構都至關重要。

自動化、病原體控制和分散式護理模式的快速發展如何重新定義設備設計、服務預期和臨床工作流程

一系列變革正在重塑血液分離術的格局，這些變革超越了產品漸進式升級，徹底改變了整個醫療管道和經營模式。細胞治療計畫的激增提升了專用細胞採集流程的重要性，並推動了分離系統和耗材的創新，以支持CAR-T細胞和幹細胞應用的高細胞存活率和溫和操作。同時，病原體去活化技術的進步正在重新定義血漿採集和輸注流程的安全標準，並增強設備性能與血站操作規程之間的一致性。

自動化和軟體主導的流程控制正在將以往的手動步驟標準化，從而減少操作人員的差異並縮短培訓時間。因此，全自動和半自動離心機及膜分離技術正吸引不同類型的買家，他們的需求取決於處理量和臨床複雜性。此外，分散式醫療模式和即時供體檢測的興起正促使供應商設計更緊湊、互通性的系統，以便在診所環境中部署。法律規範和報銷管道也在不斷發展，為臨床應用開闢了新的途徑，同時也對臨床證據和上市後監測提出了更高的要求。最後，供應鏈韌性和環境永續性正成為策略重點，影響著套件和配件的材料選擇，並促使製造商重新思考物流和供應商關係。這些轉變正在加速從銷售獨立產品向提供整合服務和解決方案的轉變，這些服務和解決方案將儀器、耗材和數據主導的支援相結合。

檢驗關稅主導的進口壓力對整個生態系統的供應鏈、採購選擇和採購時間表的營運和策略影響。

由於近期政策週期中實施的關稅措施，影響血液分離設備採購的政策環境發生了顯著變化，迫使企業重新評估其採購、庫存和生產佈局。關稅主導的進口零件和成品系統成本壓力，凸顯了供應商多元化和近岸外包策略的重要性，採購團隊需要在單位成本、交貨日期確定性和供應商長期可靠性之間權衡取捨。對許多相關人員，這意味著在供應商資質審核方面採取更加謹慎的態度，更加關注零件來源、供應商財務韌性以及應對未來貿易中斷的合約保障措施。

臨床醫生和醫院採購部門已採取措施，延長關鍵耗材（尤其是易受供應鏈波動影響的一次性試劑套件和配件）的庫存前置作業時間。同時，製造商加快了尋找替代供應來源的步伐，在可行的情況下投資本地生產能力，並重新設計包裝和物流，以減輕關稅的影響。由於專用細胞分離系統和病原體去活化耗材的前置作業時間延長，因此需要儘早制定採購計畫和緊急應變計畫。

監管機構和合規團隊目前必須權衡營運需求（即供應來源多元化）與本地註冊要求和品質保證標準，以確保替代來源符合相同的臨床和安全標準。總體而言，關稅壓力正推動醫療器材製造商、零件供應商和最終用戶之間加強合作，以提高供應鏈透明度，增加關鍵SKU的庫存，並維持醫療保健的連續性和臨床研究的進度。

詳細的細分分析揭示了產品類型、臨床應用、最終用戶畫像和技術選擇如何相互交織，從而創造差異化和價值。

了解血液分離設備市場需要深入了解產品類型、應用、終端用戶、技術和患者群體。不同的產品，例如血液分離試劑套件及配件、細胞分離系統、病原體惰性系統和血漿分離系統，其採購週期和收入模式各不相同。一次性試劑套件等耗材通常能帶來持續的收入來源，並需要完善的物流；而資本密集的分離設備則需要長期的服務和培訓投入。細胞採集，包括CAR-T細胞採集和幹細胞採集，需要針對細胞活力、處理速度和封閉式工作流程進行最佳化的系統；而血漿捐獻管道（從單份血漿到來源血漿）則優先考慮處理能力、捐獻者舒適度和病原體去活化能力。研究和治療性血液分離分別對文件和性能有特定的要求，這些要求會影響設備的配置和售後支援。

終端用戶構成了另一個差異化維度。血液中心規模龐大，需要可重複的捐血流程和嚴格的監管報告；診所通常需要緊湊易用的平台來支持小批量項目；而醫院，無論是綜合醫院還是專科醫院，都需要在急診需求和手術流程效率之間取得平衡。研究機構分為學術機構和商業機構，需要專門的實驗通訊協定介面，並與製造商密切合作進行檢驗和客製化。在技​​術方面，離心式和膜分離式方法各有優劣。離心式平台有全自動和半自動兩種類型，通常強調封閉式系統操作和成熟的臨床人體工學設計；而膜分離式系統，包括批次和連續流模式，可以提供模組化設計，並針對特定應用提供不同的性能範圍。最後，成人和兒童患者群體的分類會影響設備配置、耗材規格和臨床培訓重點，因此製造商和醫療機構需要相應調整方案和配套材料。整合這些細分因素有助於開發有針對性的產品，並制定符合臨床實際情況的商業性化服務策略。

基礎設施、監管和臨床重點的區域差異將決定全球市場的採用曲線、採購行為和夥伴關係需求。

區域動態，源自於醫療基礎設施、管理體制、捐贈模式和臨床重點領域的差異，顯著影響血液分離設備的採用、支持和規模化應用。在美洲，健全的臨床網路、細胞治療檢測的高普及率以及完善的血站基礎設施，自然地催生了對先進細胞分離系統和整合耗材供應鏈的需求。該地區的採購流程往往側重於供應商的服務能力、臨床培訓項目以及在高通量中心久經考驗的運作可靠性。相反，歐洲、中東和非洲的情況更為複雜，協調的監管環境、國家血液服務模式以及波動的醫療支出影響這些地區的採用模式。儘管集中式醫療體系和國家採購機制通常傾向於標準化平台和長期服務協議，但該地區的新興市場則需要成本最佳化的解決方案和靈活的部署模式。

亞太地區機會與挑戰並存。各大城市和研究中心正迅速提升細胞治療計畫和大規模血漿採集能力，從而推動了對自動化分離設備和病原體去活化技術的需求。同時，各國不同的監管時間表、區域性生產激勵措施和報銷機制也導致技術應用速度不一。在整個亞太地區，在地化的供應鏈、臨床培訓和售後服務能力對於技術的持續應用仍然至關重要。區域相關人員越來越重視能夠提供全面解決方案的夥伴關係，這些方案不僅包括設備，還包括培訓、耗材供應保障以及數據主導的支持，以最佳化臨床效率和保障捐血者安全。

技術差異化、耗材生態系統和卓越服務如何決定設備供應商的競爭優勢和夥伴關係關係優先事項

設備製造商、耗材供應商和服務供應商之間的競爭動態取決於技術差異化、售後市場收入導向和臨床支援能力。市場領導往往會大力投資其耗材生態系統（一次性試劑套件和配件），這不僅能確保持續的需求，還能提高終端用戶的轉換成本。同時，隨著醫院和血站尋求能夠減少操作人員差異並簡化培訓流程的供應商，軟體工具、自動化程度和整合臨床支援服務等方面的差異化正成為採購談判中的決定性因素。

製造商與研究機構之間的合作正在加速細胞採集系統的創新週期，尤其是針對CAR-T細胞和幹細胞療法的客製化系統。策略夥伴關係、共同開發契約和臨床試驗支援安排有助於彌合實驗室方法與可擴展臨床工作流程之間的差距。此外，在執行時間直接影響臨床吞吐量和捐贈者保留率的市場中，提供​​強大全球服務網路（包括本地零件供應和快速回應的技術支援）的公司將獲得競爭優勢。長期策略，包括投資本地製造、採用可逐步升級的模組化產品架構以及永續性，正變得越來越重要。總而言之，這些方法共同建構了一個競爭格局，在這個格局中，技術性能、服務品質和供應安全與設備規格同等重要。

製造商和供應商可採取的切實可行的策略重點，以增強供應鏈韌性、加速臨床應用並獲得持續的收入來源。

為了掌握臨床和商業機遇，產業領導者應採取多管齊下的策略，兼顧短期營運韌性和長期創新。首先，應優先考慮關鍵耗材的供應鏈透明度和冗餘性，具體措施包括：對多家供應商進行資格認證、最佳化一次性套件庫存策略，以及評估區域生產或按需付費模式，以減少進口中斷的影響。其次，應投資自動化和軟體功能，提高細胞採集和血漿捐贈流程的效率和臨床一致性，從而減少操作人員的差異並縮短訓練週期。第三，應開發模組化產品架構，使客戶無需更換整個系統即可升級功能，例如病原體去活化模組或增強型資料介面，從而提高產品生命週期價值並簡化採購決策。

此外，我們將透過支持研究者主導的臨床試驗以及與學術和商業研究機構的合作開發項目，加強臨床夥伴關係。這些合作將加速新通訊協定的檢驗，並建立支持其應用的證據庫。從商業性角度來看，我們將透過提供包含資本設備、耗材訂閱和基於績效的服務承諾的捆綁式方案，使我們的定價模式與最終用戶的經濟效益相符。從監管角度來看，我們將協調在主要司法管轄區的申報工作，並制定健全的上市後監測策略，以滿足不斷變化的安全預期。最後，我們將把永續性和循環經濟的考量納入產品設計和物流規劃，以應對日益成長的環境和採購要求，同時清晰地向客戶傳達這些努力，使其成為機構採購決策中的差異化優勢。

透過對臨床訪談、技術文件、監管記錄和採購分析進行嚴格的三角驗證，確保了基於證據的洞察和業務相關性。

本執行摘要的分析結合了針對血液分離設備技術和操作特性而製定的一手和二手證據。一手研究包括對來自醫院、血站、診所和研究機構的臨床使用者進行結構化訪談，以及與設備工程師、供應鏈經理和法規專家進行討論，以了解實際應用中的挑戰和供應商績效的考量。二手研究則查閱了設備手冊、監管申報文件、臨床實驗室註冊資訊、同行評審文獻和技術白皮書，以檢驗性能聲明、追蹤技術發展並評估其與臨床通訊協定的一致性。

補充資訊包括分析採購模式和服務模式、審查專利格局以識別創新趨勢，以及考察影響組件採購和物流的政策和貿易趨勢。在適用情況下，我們比較了離心式和膜分離技術的技術規範，以了解自動化能力和耗材用量。所有研究結果均透過多方交叉資訊來源進行三角檢驗，以確保其可靠性和對決策者的相關性。在整個研究過程中，我們專注於臨床應用性和操作可行性，而非推測性預測，最終得出的見解旨在為採購、研發優先排序和策略夥伴關係提供資訊。

整合臨床、技術和營運方面的必要因素，從而確定實現持久性血液分離設備應用和商業性成功的路徑。

技術進步和臨床需求正在推動新的系統功能和服務模式的出現，而政策和供應鏈壓力則正在重塑採購和生產選擇。自動化、改進的病原體控制和客製化耗材設計的整合，使得更安全、更有效率的工作流程成為可能，從而支持高通量血漿採集和敏感細胞治療採集。同時，關稅驅動的進口動態和區域監管差異凸顯了製定積極主動的供應鏈策略和本地支援能力的重要性。

顯然，對於價值鏈上的所有相關人員而言，將產品開發與臨床工作流程相契合、透過可靠的物流和培訓確保耗材的持續收入，以及投資於能夠加速臨床檢驗的夥伴關係關係至關重要。透過將技術性能與強大的服務產品和持續的供應相結合，製造商和供應商可以提供既滿足當前營運需求又滿足長期臨床目標的解決方案。對於那些以整體視角看待醫療器材——將其視為包含耗材、軟體、臨床證據和服務在內的生態系統的一部分——的組織而言，未來的道路是暢通的。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在血球分離術工作流程中採用自動化細胞處理和人工智慧驅動的最佳化
  • 在全球健康危機的背景下，對康復期血漿採集設備的需求正在上升。
  • 向適用於遠端和移動環境的可攜式和照護現場血液分離系統的過渡
  • 增加一次性試劑套件的使用，以降低交叉感染的風險
  • 亞太地區新興的血液分離術市場成長主要得益於醫療保健政策的支持。

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 依產品類型分類的血液分離設備市場

  • 血漿分離術套件及配件
  • 細胞分離系統
  • 病原體去活化系統
  • 電漿分離系統

第9章 按應用分類的血液分離設備市場

  • 細胞收集
    • CAR T 細胞採集
    • 幹細胞採集
  • 血漿捐獻
    • 單份血漿
    • 提供來源血漿
  • 研究用途
  • 治療性血液分離術

第10章 按最終用戶分類的血液分離設備市場

  • 血液中心
  • 診所
  • 醫院
    • 綜合醫院
    • 專科醫院
  • 研究所
    • 學術機構
    • 商業實驗室

第11章 按技術分類的血液分離設備市場

  • 離心技術
    • 全自動系統
    • 半自動系統
  • 膜技術
    • 批次處理系統
    • 連續流系統

第12章 依病患類型分類的血液分離設備市場

  • 成人
  • 孩子們

第13章 區域血液分離設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的血液分離設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國血液分離設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Terumo Blood and Cell Technologies, Inc.
    • Haemonetics Corporation
    • Fresenius Kabi AG
    • Macopharma SAS
    • B. Braun Melsungen AG
    • Miltenyi BIoTec GmbH
    • Grifols, SA
    • Asahi Kasei Medical Co., Ltd.
    • Cerus Corporation
    • Fenwal, Inc.
Product Code: MRR-ED54C46E8736

The Apheresis Equipment Market is projected to grow by USD 6.45 billion at a CAGR of 9.34% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.15 billion
Estimated Year [2025] USD 3.45 billion
Forecast Year [2032] USD 6.45 billion
CAGR (%) 9.34%

Setting the scene for apheresis equipment: clinical drivers, technology choices, and operational realities shaping procurement and clinical adoption

Apheresis equipment sits at the intersection of clinical care, cellular therapy innovation, and donor management, shaping how blood components and therapeutic cells are collected, processed, and delivered. Recent advances in system automation, consumable design, and pathogen mitigation have expanded the functional scope of devices, enabling more precise cell collection workflows for CAR T and stem cell therapies, while supporting scalable plasma donation and therapeutic apheresis procedures. Concurrently, the diversification of settings-from specialized hospitals and blood centers to research institutes and community clinics-has driven demand for a wider array of device form factors and service models, with a growing emphasis on usability, safety, and downstream integration with clinical laboratories.

In practical terms, stakeholders must balance capital procurement with recurring consumable needs, integrate technology choices that align with clinical protocols and patient types, and maintain supply chain continuity for critical kits and accessories. Technology choices such as centrifugal and membrane platforms continue to influence workflow design, with implications for automation level, throughput, and clinical staff training. End users including general and specialty hospitals, blood centers, and both academic and commercial research institutes prioritize reliability, vendor support, and clinical evidence when selecting equipment. Meanwhile, regulatory scrutiny and donor safety requirements shape device acceptance and clinical uptake across geographies. Taken together, these forces make the apheresis equipment environment both technically complex and strategically consequential for providers, manufacturers, and research organizations.

How rapid advances in automation, pathogen control, and decentralized care models are redefining device design, service expectations, and clinical workflows

The apheresis landscape is being reshaped by a set of transformative shifts that extend beyond incremental product upgrades to alter entire care pathways and business models. The surge in cell therapy programs has elevated the importance of dedicated cell collection workflows, prompting innovation in separator systems and consumables that support high-viability yields and gentle handling for CAR T and stem cell applications. At the same time, improvements in pathogen inactivation technologies are redefining safety expectations for plasma collection and transfusion workflows, prompting greater alignment between device capabilities and blood center protocols.

Automation and software-driven process control are enabling previously manual steps to be standardized, which reduces operator variability and shortens training timelines. As a consequence, full and semi-automation options within centrifugal and membrane technology families are attracting different types of buyers based on throughput needs and clinical complexity. Additionally, a move toward decentralized models of care and point-of-donor testing is nudging suppliers to design more compact, interoperable systems that can be deployed in clinic-level settings. Regulatory frameworks and reimbursement pathways are also evolving in tandem, creating new pathways for clinical adoption while imposing higher expectations for clinical evidence and post-market surveillance. Finally, supply chain resiliency and environmental sustainability have emerged as strategic priorities, influencing material selection for kits and accessories and prompting manufacturers to rethink logistics and vendor relationships. Together, these shifts are accelerating the transition from isolated product sales to integrated service and solution offerings that combine devices, consumables, and data-driven support.

Examining the operational and strategic consequences of tariff-driven import pressures on supply chains, sourcing choices, and procurement timelines across the ecosystem

The policy environment influencing apheresis equipment procurement has changed materially due to tariff measures enacted in recent policy cycles, prompting organizations to reassess sourcing, inventory, and manufacturing footprints. Tariff-driven cost pressures on imported components and finished systems have increased emphasis on supplier diversification and nearshoring strategies, with procurement teams evaluating trade-offs between unit price, delivery certainty, and long-term vendor reliability. For many stakeholders, this has translated into a more deliberate approach to supplier qualification, with greater scrutiny of component origin, supplier financial resilience, and contractual protections against future trade disruption.

Clinicians and hospital procurement functions have responded by extending inventory lead times for critical consumables, especially single-use kits and accessories that are susceptible to supply chain variability. At the same time, manufacturers have accelerated efforts to secure alternative supply sources, invest in localized manufacturing capacity where feasible, and redesign packaging and logistics to mitigate tariff impacts. These adaptations have also affected how research institutes and commercial entities plan clinical programs: extended lead times for specialized cell separator systems or pathogen inactivation consumables necessitate earlier procurement planning and contingency reserves.

Regulatory and compliance teams have had to reconcile the operational need to diversify sources with local registration requirements and quality assurance standards, ensuring that alternate suppliers meet the same clinical and safety benchmarks. In aggregate, tariff pressures have nudged the ecosystem toward greater supply-chain transparency, increased inventories for critical SKUs, and closer collaboration between device manufacturers, component suppliers, and end users to preserve continuity of care and clinical research timelines.

Detailed segmentation analysis revealing how product categories, clinical applications, end user profiles, and technology choices intersect to drive differentiation and value

Understanding the apheresis equipment landscape requires a granular view across product types, applications, end users, technologies, and patient populations, each of which shapes purchasing logic and clinical deployment. Product distinctions between apheresis kits and accessories, cell separator systems, pathogen inactivation systems, and plasma separation systems drive different procurement cycles and revenue models; consumables such as single-use kits often underpin recurring revenue streams and demand well-established logistics, whereas capital-intensive separators require long-term service and training investments. Application-level segmentation further refines this dynamic: cell collection activities, encompassing both CAR T cell collection and stem cell collection, demand systems optimized for cell viability, processing speed, and closed-system workflows, while plasma donation pathways-ranging from single donor plasma to source plasma-prioritize throughput, donor comfort, and pathogen reduction capabilities. Research use and therapeutic apheresis each impose specific documentation and performance expectations that influence device configuration and aftermarket support.

End users present another axis of differentiation. Blood centers operate at scale with repeatable donor flows and stringent regulatory reporting, clinics often seek compact, user-friendly platforms to support lower-volume programs, and hospitals-whether general or specialty-balance a mix of acute care needs with procedural throughput considerations. Research institutes, divided into academic and commercial entities, demand specialized interfaces for experimental protocols and close collaboration with manufacturers on validation and customization. On the technology front, centrifugal and membrane approaches offer distinct trade-offs: centrifugal platforms, available in full automation and semi-automation variants, generally emphasize closed-system handling and established clinical ergonomics, while membrane-based systems, including batch and continuous flow formats, can offer modularity and different performance envelopes for specific applications. Finally, patient type segmentation between adult and pediatric populations affects device settings, consumable sizing, and clinical training priorities, requiring manufacturers and providers to tailor protocols and support materials accordingly. Synthesizing these segmentation layers enables targeted product development and commercially viable service strategies that match clinical realities.

Regional nuances in infrastructure, regulation, and clinical focus that determine adoption curves, procurement behavior, and partnership needs across global markets

Regional dynamics significantly shape how apheresis equipment is adopted, supported, and scaled, with differences rooted in healthcare infrastructure, regulatory regimes, donation models, and clinical focus areas. In the Americas, robust clinical networks, a high prevalence of cell therapy trials, and established blood center infrastructures create natural demand for advanced cell separator systems and integrated consumable supply chains. Procurement processes in this region tend to emphasize vendor service capabilities, clinical training programs, and evidence of operational reliability across high-throughput centers. Conversely, Europe, the Middle East & Africa features a more heterogeneous landscape where regulatory harmonization, national blood service models, and variable healthcare spending influence adoption patterns; centralized health systems and national procurement mechanisms often favor standardized platforms and long-term service arrangements, while emerging markets within the region require cost-optimized solutions and flexible deployment models.

Asia-Pacific presents a diverse mix of opportunities and constraints: major metropolitan centers and research hubs are rapidly building capacity for cell therapy programs and high-volume plasma collection, driving demand for both automated separators and pathogen inactivation technologies. At the same time, differences in regulatory timelines, local manufacturing incentives, and reimbursement frameworks create a patchwork of adoption speeds across countries. Across all regions, localization of supply chains, clinical training, and aftermarket service capabilities remain critical for sustained adoption. Regional stakeholders increasingly prioritize partnerships that deliver not just equipment but a comprehensive package of training, consumable supply assurance, and data-driven support to optimize clinical throughput and donor safety.

How technology differentiation, consumable ecosystems, and service excellence determine competitive advantage and partnership priorities among equipment suppliers

Competitive dynamics among device manufacturers, consumable suppliers, and service providers are defined by a combination of technological differentiation, aftermarket revenue focus, and clinical support capabilities. Market leaders tend to invest heavily in consumables ecosystems-single-use kits and accessories-that lock in recurring demand and create high switching costs for end users. At the same time, differentiation through software tools, automation levels, and integrated clinical support services is becoming a decisive factor in procurement discussions, as hospitals and blood centers seek vendors that can reduce operator variability and streamline training.

Collaboration between manufacturers and research institutes is accelerating innovation cycles, especially for cell collection systems tailored to CAR T and stem cell protocols. Strategic partnerships, co-development agreements, and clinical trial support arrangements help bridge the gap between laboratory methods and scalable clinical workflows. Additionally, companies that offer robust global service networks, including local parts availability and responsive technical support, gain competitive advantage in markets where uptime is directly linked to clinical throughput and donor retention. Longer-term strategies increasingly include investments in localized manufacturing, modular product architectures that permit incremental upgrades, and sustainability initiatives to reduce the environmental footprint of consumables and packaging. Collectively, these approaches shape a competitive environment where technical performance, service quality, and supply security matter as much as device specifications.

Actionable strategic priorities for manufacturers and providers to strengthen supply resilience, accelerate clinical adoption, and capture recurring revenue streams

Industry leaders should adopt a multifaceted strategy that balances near-term operational resilience with long-term innovation to capture clinical and commercial opportunities. First, prioritize supply chain transparency and redundancy for critical consumables by qualifying multiple suppliers, optimizing inventory policies for single-use kits, and evaluating regional manufacturing or tolling options to mitigate import-related disruptions. Second, invest in automation and software capabilities that reduce operator variability and shorten training cycles, thereby improving throughput and clinical consistency for both cell collection and plasma donation workflows. Third, develop modular product architectures that allow customers to upgrade functionality-such as pathogen inactivation modules or enhanced data interfaces-without full system replacement, increasing lifetime value and easing procurement decisions.

Additionally, strengthen clinical partnerships by supporting investigator-initiated trials and co-development programs with academic and commercial research institutes; these collaborations accelerate validation of novel protocols and create a pipeline of evidence that underpins adoption. For commercial strategy, align pricing models with end-user economics by offering bundled options that combine capital equipment, consumable subscriptions, and performance-based service commitments. From a regulatory perspective, harmonize submissions across key jurisdictions and prepare robust post-market surveillance strategies to meet evolving safety expectations. Finally, embed sustainability and circular-economy considerations into product design and logistics planning to address growing environmental and procurement requirements, while communicating these efforts clearly to customers as a differentiator in institutional purchasing decisions.

A rigorous triangulation of clinical interviews, technical documentation, regulatory records, and procurement analysis to ensure evidence-based insights and operational relevance

The analysis underpinning this executive summary combined primary and secondary evidence tailored to the technical and operational characteristics of apheresis equipment. Primary research included structured interviews with clinical users across hospitals, blood centers, clinics, and research institutes, as well as discussions with device engineers, supply chain managers, and regulatory specialists to capture real-world deployment challenges and vendor performance considerations. Secondary research encompassed device manuals, regulatory filings, clinical trial registries, peer-reviewed literature, and technical white papers to validate performance claims, trace technology evolution, and assess compatibility with clinical protocols.

Supplementary inputs included analyses of procurement patterns and service models, review of patent landscapes to identify innovation trends, and examination of policy and trade developments affecting component sourcing and logistics. Where applicable, technical specifications were compared across centrifugal and membrane platforms to understand automation capabilities and consumable footprints. All findings were triangulated through cross-validation from multiple sources to ensure reliability and relevance for decision-makers. Throughout the research process, emphasis was placed on clinical applicability and operational feasibility rather than speculative projections, resulting in insights designed to inform procurement, R&D prioritization, and strategic partnerships.

Synthesis of clinical, technological, and operational imperatives that define the path to durable adoption and commercial success in apheresis equipment

The collective insights reveal an apheresis ecosystem in transition: technological advances and clinical demand are spurring new system capabilities and service models, while policy and supply chain pressures are reshaping procurement and manufacturing choices. The convergence of automation, improved pathogen control, and tailored consumable design is enabling safer, more efficient workflows that support both high-throughput plasma collection and delicate cell therapy harvests. At the same time, tariff-driven import dynamics and regional regulatory variability underscore the need for proactive supply chain strategies and localized support capabilities.

For stakeholders across the value chain, the imperative is clear: align product development with clinical workflows, secure recurring consumable revenue through reliable logistics and training, and invest in partnerships that accelerate clinical validation. By combining technical performance with robust service offerings and supply continuity, manufacturers and providers can deliver solutions that meet both immediate operational needs and long-term clinical goals. The path forward favors organizations that think holistically about devices as part of an ecosystem encompassing consumables, software, clinical evidence, and service.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of automated cell processing and AI-driven optimization in apheresis workflows
  • 5.2. Rising demand for convalescent plasma collection devices amid global health crises
  • 5.3. Shift toward portable and point-of-care apheresis systems for remote or mobile settings
  • 5.4. Growing utilization of single-use disposable kits to reduce cross-contamination risks
  • 5.5. Expansion of emerging apheresis markets in Asia-Pacific driven by supportive healthcare policies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Apheresis Equipment Market, by Product Type

  • 8.1. Apheresis Kits & Accessories
  • 8.2. Cell Separator Systems
  • 8.3. Pathogen Inactivation Systems
  • 8.4. Plasma Separation Systems

9. Apheresis Equipment Market, by Application

  • 9.1. Cell Collection
    • 9.1.1. Car T Cell Collection
    • 9.1.2. Stem Cell Collection
  • 9.2. Plasma Donation
    • 9.2.1. Single Donor Plasma
    • 9.2.2. Source Plasma
  • 9.3. Research Use
  • 9.4. Therapeutic Apheresis

10. Apheresis Equipment Market, by End User

  • 10.1. Blood Centers
  • 10.2. Clinics
  • 10.3. Hospitals
    • 10.3.1. General Hospitals
    • 10.3.2. Specialty Hospitals
  • 10.4. Research Institutes
    • 10.4.1. Academic Institutes
    • 10.4.2. Commercial Institutes

11. Apheresis Equipment Market, by Technology

  • 11.1. Centrifugal Technology
    • 11.1.1. Full Automation Systems
    • 11.1.2. Semi Automation Systems
  • 11.2. Membrane Technology
    • 11.2.1. Batch Systems
    • 11.2.2. Continuous Flow Systems

12. Apheresis Equipment Market, by Patient Type

  • 12.1. Adult
  • 12.2. Pediatric

13. Apheresis Equipment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Apheresis Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Apheresis Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Terumo Blood and Cell Technologies, Inc.
    • 16.3.2. Haemonetics Corporation
    • 16.3.3. Fresenius Kabi AG
    • 16.3.4. Macopharma S.A.S.
    • 16.3.5. B. Braun Melsungen AG
    • 16.3.6. Miltenyi Biotec GmbH
    • 16.3.7. Grifols, S.A.
    • 16.3.8. Asahi Kasei Medical Co., Ltd.
    • 16.3.9. Cerus Corporation
    • 16.3.10. Fenwal, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. APHERESIS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. APHERESIS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. APHERESIS EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS KITS & ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL SEPARATOR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATHOGEN INACTIVATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CAR T CELL COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY STEM CELL COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SINGLE DONOR PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SOURCE PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COMMERCIAL INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY FULL AUTOMATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY SEMI AUTOMATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY BATCH SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CELL COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PLASMA DONATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY CENTRIFUGAL TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PA